| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 2 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 4 | 2 | 3 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 5 | 4 | 3 | 5 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 3 |
| Expenses | 5 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | -2 | -0 | 0 | -0 | 0 | 0 | 0 | -0 | 1 | -0 | 0 | 0 | 2 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | -159 % | -22 % | 6 % | -4 % | 7 % | 14 % | 4 % | -6 % | -11 % | -3 % | 6 % | 19 % | 4 % | 11 % | 19 % | 12 % | 16 % | 17 % | 5 % | 23 % | 18 % | 11 % | 19 % | 29 % | 30 % | 33 % | 26 % | 24 % | 26 % | 24 % | 24 % | 22 % | 33 % | 22 % | 32 % | 25 % | 30 % | 28 % | 31 % | 29 % | 33 % | 39 % |
| Depreciation | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -3 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | -0 | 1 | -0 | -0 | -0 | 2 | -0 | -0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax | -1 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -3 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | 1 | -1 | -1 | -0 | 1 | -0 | -0 | -0 | 1 | -0 | -0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 |
| EPS in ₹ | -2.63 | -0.40 | -0.15 | -0.79 | -0.69 | -0.53 | -0.66 | -0.96 | 0.71 | -0.63 | -0.46 | -0.23 | 1.00 | -0.14 | -0.07 | -0.24 | 1.25 | -0.09 | -0.25 | 0.03 | 0.05 | -0.04 | 0.67 | 0.88 | 0.52 | 1.03 | 0.54 | 0.36 | 0.35 | 0.30 | 0.36 | 0.24 | 0.78 | 0.33 | 0.67 | 0.40 | 0.60 | 0.42 | 0.50 | 0.38 | 0.60 | 0.66 |
Medinova Diagnostic Service
Medinova Diagnostic Service
40.90
+0.78
(1.94%)
Key Fundamentals
Market Cap
40.00 Cr
EPS
1.89
PE Ratio
19.12
Dividend Yield
0.00 %
Industry
Healthcare Services 52 Week High
46.92
52 Week Low
32.10
PB Ratio
-33.39
Debt to Equity
0.00
Sector
Healthcare Service Provider Actual
Company News
View All News
Medinova Diagnostic Services Limited has received the certified true copy of the National Company Law Tribunal order dated October 13, 2025, approving its amalgamation with Vijaya Diagnostic Centre Limited. Under the scheme, Medinova serves as the transferor company while Vijaya Diagnostic Centre is the transferee company. The merger will become effective when both companies file the certified true copy of the NCLT order and the amalgamation scheme with the Registrar of Companies in Hyderabad. The effective date will be communicated to stock exchanges once the filing is completed and the scheme becomes operational.
The National Company Law Tribunal, Hyderabad Bench has sanctioned the scheme of amalgamation between Medinova Diagnostic Services Limited and Vijaya Diagnostic Centre Limited. The final order was pronounced on October 13, 2025, with an appointed date of April 1, 2024. Under the scheme, shareholders of Medinova will receive 1 equity share of Vijaya for every 22 shares held. Vijaya Diagnostic, which holds 62.14% stake in Medinova, will see its shares in the transferor company cancelled. Both companies operate in diagnostic services including pathological investigations, radiology, and nuclear medicine. The amalgamation aims to create synergies, reduce operational costs, and simplify the group structure. Medinova shares are listed on BSE while Vijaya trades on both BSE and NSE. The tribunal addressed various regulatory concerns including pending inquiries against Medinova and MSME dues, with the transferee company providing necessary undertakings for compliance.
Medinova Diagnostic Services Publishes Q1 FY2026 Financial Results in NewspapersJul 28, 2025
Medinova Diagnostic Services Limited has published its unaudited financial results for the quarter ended June 30, 2025, in Financial Express (English) and Nava Telangana (Telugu) newspapers. The company submitted copies of these newspaper advertisements to BSE Limited as required under SEBI listing regulations. The publication includes both standalone and consolidated financial results for the quarter. Company Secretary Hansraj Singh signed the regulatory filing dated July 28, 2025, confirming compliance with disclosure requirements.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,108.10 | #1 26,445.40 | 50.26 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 43.79 | |
992.05 | 10,295.10 | 67.60 | 699.70 | 23.06 | 144 | 22.54 | 42.12 | |
1,938.20 | 10,103.00 | 65.93 | 1,346.30 | 10.64 | 146 | 18.90 | 38.21 | |
1,243.90 | 6,760.50 | 52.12 | 702.20 | 20.80 | 91 | 81.06 | 51.86 | |
779.10 | 2,643.10 | 31.52 | 742.70 | 16.70 | 78 | 14.53 | 40.44 | |
300.55 | 1,563.20 | 48.21 | 255.90 | 15.11 | 31 | 19.48 | 49.29 | |
1,378.00 | 1,176.60 | 24.27 | 111.60 | 28.72 | 48 | 11.50 | 43.85 | |
305.30 | 986.10 | #1 -6.49 | 1,170.80 | -18.47 | -134 | -35.12 | 49.51 | |
261.00 | 503.60 | 19.21 | 147.80 | #1 134.60 | 19 | #1 444.44 | 44.37 | |
163.30 | 117.60 | 76.21 | 41.80 | 13.28 | 2 | 0.00 | 31.57 |
Growth Rate
Revenue Growth
-3.85 %
Net Income Growth
-5.00 %
Cash Flow Change
-5.62 %
ROE
137.60 %
ROCE
-44.27 %
EBITDA Margin (Avg.)
9.67 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 10 | 13 | 9 | 6 | 5 | 4 | 4 | 4 | 5 | 5 | 7 |
| Fixed Assets | 7 | 9 | 7 | 5 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Current Assets | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 4 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 4 | 4 | 2 | 2 | 1 | 2 | 3 | 3 | 3 | 4 | 4 |
| Total Liabilities | 10 | 13 | 9 | 6 | 5 | 4 | 4 | 4 | 5 | 5 | 7 |
| Current Liabilities | 15 | 13 | 11 | 10 | 9 | 9 | 8 | 5 | 4 | 3 | 3 |
| Non Current Liabilities | 2 | 8 | 7 | 6 | 5 | 5 | 4 | 6 | 6 | 5 | 5 |
| Total Equity | -7 | -8 | -10 | -10 | -9 | -9 | -8 | -7 | -5 | -3 | -1 |
| Reserve & Surplus | -16 | -18 | -20 | -20 | -19 | -19 | -17 | -17 | -15 | -13 | -11 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 1 | 0 |
| Investing Activities | -5 | -0 | 0 | -0 | -0 | -0 | -2 | -0 | -0 | -2 |
| Operating Activities | -1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 3 |
| Financing Activities | 5 | 0 | -2 | -1 | -1 | -1 | 0 | -1 | -1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % | 62.14 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 36.29 % | 36.05 % | 36.06 % | 36.19 % | 36.14 % | 36.01 % | 36.03 % | 35.96 % | 35.94 % | 36.00 % | 36.02 % | 35.49 % | 35.58 % | 36.09 % | 36.29 % | 35.90 % | 35.97 % | 35.52 % | 34.96 % |
| Others | 1.57 % | 1.82 % | 1.80 % | 1.67 % | 1.73 % | 1.85 % | 1.83 % | 1.91 % | 1.93 % | 1.86 % | 1.84 % | 2.38 % | 2.28 % | 1.77 % | 1.58 % | 1.97 % | 1.89 % | 2.35 % | 2.90 % |
| No of Share Holders | 9,494 | 9,582 | 9,804 | 9,906 | 9,860 | 9,900 | 9,937 | 9,972 | 9,926 | 9,921 | 10,041 | 10,205 | 10,295 | 10,544 | 10,730 | 10,931 | 10,847 | 10,750 | 10,609 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 03 Sept 2024 |  Annual General Meeting | NA | 03 Sept 2024 | 35.00 | 37.36 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 38.45 | 38.00 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 39.00 | 35.75 |
| 25 Apr 2025 |  Extraordinary General Meeting | NA | 25 Apr 2025 | 38.02 | 41.17 |
| 03 May 2025 | Quarterly Result Announcement | NA | 03 May 2025 | 41.05 | 42.18 |
| 26 Jul 2025 | Quarterly Result Announcement | NA | 26 Jul 2025 | 41.63 | 42.38 |
| 03 Sept 2025 | Annual General Meeting | NA | 03 Sept 2025 | 40.80 | 40.65 |
Announcements
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement3 days ago
3 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-CessationSep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 03, 2025
Sep 03, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 03, 2025
Sep 03, 2025Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Reg. 34 (1) Annual Report.Aug 11, 2025
Aug 11, 2025Notice Of 32Nd Annual General Meeting Of The CompanyAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Information Relating To 32Nd Annual General Meeting (AGM)Aug 09, 2025
Aug 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Jul 28, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th July 2025Jul 26, 2025
Jul 26, 2025Unaudited Financial Results For The Quarter Ended 30Th June 2025Jul 26, 2025
Jul 26, 2025Board Meeting Intimation for Unaudited Financial Result For The Quarter Ended June 30 2025.Jul 18, 2025
Jul 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 05, 2025
May 05, 2025Results - For FY 2024-25May 03, 2025
May 03, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Apr 28, 2025Board Meeting Intimation for Approval Of Audited Financial Results Of The CompanyApr 26, 2025
Apr 26, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingApr 25, 2025
Apr 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Mar 25, 2025Notice Of Meeting Of The Equity Shareholders Of Medinova Diagnostic Services Limited To Be Convened As Per The Directions Provided In The Order Of The HonBle National Company Law TribunalMar 25, 2025
Mar 25, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Feb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Feb 01, 2025Integrated Filing (Financial)Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2025
Jan 30, 2025Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2025
Jan 30, 2025Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 23, 2025
Jan 23, 2025Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 Among Other Corporate Matters.Jan 23, 2025
Jan 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Receipt Of Observation Letter From BSE Limited With No Adverse Observations For The Scheme Of AmalgamationDec 07, 2024
Dec 07, 2024Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Nov 16, 2024
Nov 16, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Oct 30, 2024Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October 2024Oct 29, 2024
Oct 29, 2024Un-Audited Financial Results For The Quarter Ended September 30, 2024Oct 29, 2024
Oct 29, 2024Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2024; And Other Corporate MattersOct 19, 2024
Oct 19, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 03, 2024
Oct 03, 2024Closure of Trading WindowSep 25, 2024
Sep 25, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 04, 2024
Sep 04, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 03, 2024
Sep 03, 2024Technical Indicators
RSI(14)
Neutral 53.23
ATR(14)
Less Volatile 1.35
STOCH(9,6)
Neutral 35.22
STOCH RSI(14)
Neutral 64.52
MACD(12,26)
Bullish 0.07
ADX(14)
Weak Trend 11.01
UO(9)
Bearish 50.71
ROC(12)
Uptrend And Accelerating 1.82
WillR(14)
Neutral -45.44
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
